首页> 外文期刊>Journal of Ophthalmology >Comparative Efficacy of Phacotrabeculectomy versus Trabeculectomy with or without Later Phacoemulsification: A Systematic Review with Meta-Analyses
【24h】

Comparative Efficacy of Phacotrabeculectomy versus Trabeculectomy with or without Later Phacoemulsification: A Systematic Review with Meta-Analyses

机译:PhacotraBeceCelectomy对或没有以后的沉乳乳化的比较疗效与术治乳化的术:与Meta-Analys的系统审查

获取原文
           

摘要

There is no consensus on the surgical management of coexisting cataract in patients who undergo glaucoma surgery. In this study, we systematically reviewed the literature to compare the efficacy and safety of phacotrabeculectomy and trabeculectomy either alone or followed by later phacoemulsification. We systematically searched the literature databases PubMed/MEDLINE, EMBASE, and the Cochrane Central. Eligible studies were comparative trials of eyes with glaucoma that underwent either phacotrabeculectomy or trabeculectomy with or without later phacoemulsification. Our primary outcome measure was intraocular pressure (IOP) control closest to 12 months. Secondary outcome measures were efficacy closest to 12 months in terms of visual acuity, visual field, prevalence of complications, needling or revision, number of antiglaucomatous medications, and surgical success. We identified 25 studies with a total of 4,749 eyes. The IOP did not differ significantly between those who underwent phacotrabeculectomy versus trabeculectomy with (MD: 0.63, CI95%: ?0.32, 1.59, ) or without later phacoemulsification (MD: ?0.52, CI95%: ?1.45, 0.40, ). However, phacotrabeculectomy was associated with lower risk of complications (RR: 0.80, CI95%: 0.67, 0.95, ) and better visual acuity corresponding to a 1.4-line difference (MD: ?0.14, CI95%: ?0.27, ?0.95, ) compared to trabeculectomy. Other secondary outcome measures did not differ significantly (visual field, needling or revision, number of antiglaucomatous medications, and surgical success). In conclusion, postoperative IOP is comparable, and the number of complications is lower when phacotrabeculectomy is compared to trabeculectomy with or without later phacoemulsification in patients with coexisting glaucoma and cataract. However, our study also reveals that the level of evidence is low, and randomized clinical trials are warranted.
机译:对接受青光眼手术的患者共存白内障的手术管理没有共识。在这项研究中,我们系统地审查了文献,以比较单独的磷酸切除术和TRABECELECTOMY的疗效和安全性,或者随后进行沉淀乳化。我们系统地搜索了文献数据库PubMed / Medline,Embase和Cochrane Central。符合条件的研究是眼睛与青光眼的比较试验,它经历了无论骨髓切除术或没有以后的Phacoemumsifice的phacoTraBecectomy或Trabeculectomy。我们的主要结果测量是最接近12个月的眼内压(IOP)控制。在视力,视野,并发症的患病率,并发症患病率,针刺或修改的患病率最近的疗效是最接近12个月的疗效,并进行抗原瘤药物的疗效和手术成功。我们确定了25项研究,共计4,749只眼睛。在接受PhacotraBececulecul切除术与TraBececulectomy的那些与(MD:0.63,CI95%:α0.32,1.59)或没有以后的Phacoem乳化(MD:0.52,CI95%:α1.45,0.40,)之间的IOP之间没有显着差异。然而,phacotrabeculecectomy与较低的并发症风险有关(Rr:0.80,Ci95%:0.67,0.95,)和对应于1.4线差异的更好的视力(MD:?0.14,CI95%:?0.27,?0.95,)与Trabecectomy相比。其他次要结果措施并没有显着差异(视野,针刺或修订,抗抛光药物数量和手术成功)。总之,术后IOP是可比性的,并且当与在共存青光眼和白内障的患者中的术治术中的分枝切除术相比,当PhacoTraBecececulectomys比较时,并发症的数量较低。但是,我们的研究还揭示了证据水平低,随机临床试验是有保证的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号